The label now says the drug is only intended for patients in early stages of the disease — not millions of others with more advanced Alzheimer’s. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.